ARCHIVES

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Susan Braun Named CEO, Komen Foundation; NCCF Research Fellowship Honors Norman

July 12, 1996

In Brief: Adamson Takes Job at Soft Drink Association; Zack Hall to Direct Neurological Institute

August 12, 1994

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

Blacks Half As Likely To Get Surgery For Esophageal Cancer

January 28, 2005

First NCI Director To Resign Due To Presidential Election?

December 15, 2000

Continuing Progress Reported On Breast Cancer Treatment; Mammography Controversy Cooled

November 26, 1976